Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation
- PMID: 9502647
- DOI: 10.1016/s0735-1097(97)00530-5
Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation
Abstract
Objectives: This study compared the long-term effects of complete atrioventricular junction (AVJ) ablation with those of AVJ modification in patients with medically refractory atrial fibrillation (AF).
Background: Comparisons between the long-term effects of AVJ ablation with those of AVJ modification in patients with medically refractory AF have not been systematically studied.
Methods: Sixty patients with medically refractory AF were randomly assigned to receive complete AVJ ablation with permanent pacing or AVJ modification. Subjective perception of quality of life (QOL) was assessed by a semiquantitative questionnaire before and 1 and 6 months after ablation. Cardiac performance was evaluated by echocardiography and radionuclide angiography within 24 h (baseline) and at 1 and 6 months after ablation.
Results: Both methods were associated with significant improvement in general QOL and a significant reduction in the frequency of major symptoms and symptoms during attacks. The frequency of hospital admission and emergency room visits and antiarrhythmic drug trials significantly decreased after ablation in both groups. However, patients after complete AVJ ablation had a significantly greater improvement in general QOL and a significantly reduced frequency of major symptoms and symptoms during attacks (including palpitation, dizziness, chest oppression, blurred vision and syncope). Left ventricular (LV) systolic function and the ability to perform activities of daily life significantly improved after ablation in patients with depressed LV function in both groups. All improvements after ablation or modification were maintained over the 6-month follow-up period.
Conclusions: AVJ ablation with permanent pacing, as compared with AVJ modification, had a significantly greater ability to decrease the frequency of attacks and the extent of symptoms of AF, and the patients who received this procedure were more satisfied with their general well-being.
Similar articles
-
Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.J Cardiovasc Electrophysiol. 2008 Jan;19(1):19-27. doi: 10.1111/j.1540-8167.2007.00994.x. Epub 2007 Oct 24. J Cardiovasc Electrophysiol. 2008. PMID: 17971146
-
Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation.J Am Coll Cardiol. 2004 Mar 17;43(6):1013-8. doi: 10.1016/j.jacc.2003.10.038. J Am Coll Cardiol. 2004. PMID: 15028360
-
The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.J Interv Card Electrophysiol. 1998 Jun;2(2):121-35. doi: 10.1023/a:1009795330454. J Interv Card Electrophysiol. 1998. PMID: 9870004
-
Atrioventricular Junction Ablation for Atrial Fibrillation.Heart Fail Clin. 2016 Apr;12(2):245-55. doi: 10.1016/j.hfc.2015.08.020. Heart Fail Clin. 2016. PMID: 26968669 Review.
-
Atrioventricular junction ablation for atrial fibrillation.Cardiol Clin. 2014 Nov;32(4):573-83. doi: 10.1016/j.ccl.2014.07.010. Epub 2014 Sep 2. Cardiol Clin. 2014. PMID: 25443238 Review.
Cited by
-
Leadless pacemaker implant with concomitant atrioventricular node ablation: Experience with the Micra transcatheter pacemaker.J Cardiovasc Electrophysiol. 2021 Mar;32(3):832-841. doi: 10.1111/jce.14881. Epub 2021 Jan 23. J Cardiovasc Electrophysiol. 2021. PMID: 33428248 Free PMC article.
-
Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.Curr Cardiol Rep. 2002 Sep;4(5):418-25. doi: 10.1007/s11886-002-0042-4. Curr Cardiol Rep. 2002. PMID: 12169239 Review.
-
Current Role of Conduction System Pacing in Patients Requiring Permanent Pacing.Korean Circ J. 2024 Aug;54(8):427-453. doi: 10.4070/kcj.2024.0113. Epub 2024 May 7. Korean Circ J. 2024. PMID: 38859643 Free PMC article. Review.
-
Health-related quality of life relative to clinical outcomes in patients with atrial fibrillation treated with ventricular rate stabilisation pacing.Neth Heart J. 2006 Mar;14(3):81-88. Neth Heart J. 2006. PMID: 25696600 Free PMC article.
-
Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing.Eur Heart J. 2024 Dec 7;45(46):4887-4901. doi: 10.1093/eurheartj/ehae656. Eur Heart J. 2024. PMID: 39397777 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical